Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Mar 18;1(6114):683–685. doi: 10.1136/bmj.1.6114.683

Intramuscular injections of iron compounds and oncogenesis in man

K Weinbren, R Salm, G Greenberg
PMCID: PMC1603084  PMID: 630294

Abstract

To evaluate the evidence for iron compounds as local carcinogens in man, histological material and clinical reports have been reviewed in seven of the eight published cases of tumours developing at the site of intramuscular injections. The microscopical appearances suggested benign lesions in two cases and a variety of tumours in the other five. In only two cases (a rhabdomyosarcoma and a fibrosarcoma) was the interval between injections and tumour development longer than six years. Of the remaining three tumours, one was considered to be a rather slowly growing haemangiopericytoma (with an interval of two years), one appeared to be a subcutaneous lymphoma with no evidence of having arisen in the gluteal muscles, and one was a pleomorphic sarcoma with a possible five-year interval. Sarcomas induced experimentally by iron compounds differ in being less variable in type and in containing abundant iron-containing macrophages, which were negligible in these human tumours.

Although the total number of patients who have received intramuscular injections of iron compounds is not known, the present findings, in contrast to experimental work, do not support the view that such treatment carries a strong risk of tumour development.

Full text

PDF
685

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CADE S. Soft tissue tumours: their natural history and treatment. Proc R Soc Med. 1951 Jan;44(1):19–36. [PMC free article] [PubMed] [Google Scholar]
  2. Carter R. L., Mitchley B. C., Roe F. J. Induction of tumours in mice and rats with ferric sodium gluconate and iron dextran glycerol glycoside. Br J Cancer. 1968 Sep;22(3):521–526. doi: 10.1038/bjc.1968.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carter R. L., Percival W. H., Roe F. J. The effects of iron-dextran on squirrel monkeys (Saimiri sciurea). Br J Cancer. 1968 Mar;22(1):116–121. doi: 10.1038/bjc.1968.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greenberg G. Sarcoma after intramuscular iron injection. Br Med J. 1976 Jun 19;1(6024):1508–1509. doi: 10.1136/bmj.1.6024.1508-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Guccion J. G., Font R. L., Enzinger F. M., Zimmerman L. E. Extraskeletal mesenchymal chondrosarcoma. Arch Pathol. 1973 May;95(5):336–340. [PubMed] [Google Scholar]
  6. Guccion J. G., Font R. L., Enzinger F. M., Zimmerman L. E. Extraskeletal mesenchymal chondrosarcoma. Arch Pathol. 1973 May;95(5):336–340. [PubMed] [Google Scholar]
  7. HADDOW A. ADVANCES IN KNOWLEDGE OF THE CARCINOGENIC PROCESS, 1958-1962. Acta Unio Int Contra Cancrum. 1963;19:453–457. [PubMed] [Google Scholar]
  8. HADDOW A., HORNING E. S. On the carcinogenicity of an iron-dextran complex. J Natl Cancer Inst. 1960 Jan;24:109–147. [PubMed] [Google Scholar]
  9. HADDOW A., ROE F. J., MITCHLEY B. C. INDUCTION OF SARCOMATA IN RABBITS BY INTRAMUSCULAR INJECTION OF IRON-DEXTRAN ("IMFERON"). Br Med J. 1964 Jun 20;1(5398):1593–1594. doi: 10.1136/bmj.1.5398.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hedinger C. Mesenchymales Chondrosarkom der Weichteile. Schweiz Med Wochenschr. 1969 Aug 9;99(32):1142–1147. [PubMed] [Google Scholar]
  11. LIEBERMAN Z., ACKERMAN L. V. Principles in management of soft tissue sarcomas: a clinical and pathologic review of one hundred cases. Surgery. 1954 Mar;35(3):350–365. [PubMed] [Google Scholar]
  12. MacKinnon A. E., Bancewicz J. Sarcoma after injection of intramuscular iron. Br Med J. 1973 May 5;2(5861):277–279. doi: 10.1136/bmj.2.5861.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. ROBINSON C. E., BELL D. N., STURDY J. H. Possible association of malignant neoplasm with iron-dextran injection. A case report. Br Med J. 1960 Aug 27;2(5199):648–650. doi: 10.1136/bmj.2.5199.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. ROE F. J., LANCASTER M. C. NATURAL, METALLIC AND OTHER SUBSTANCES, AS CARCINOGENS. Br Med Bull. 1964 May;20:127–133. doi: 10.1093/oxfordjournals.bmb.a070305. [DOI] [PubMed] [Google Scholar]
  15. Robertson A. G., Dick W. C. Intramuscular iron and local oncogenesis. Br Med J. 1977 Apr 9;1(6066):946–946. doi: 10.1136/bmj.1.6066.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. THEDERING F. DIE VERTRAEGLICHKEIT DER EISENTHERAPIE UNTER BERUECKSICHTIGUNG DER KARZINOGENEN WIRKUNG DES DEXTRANEISENKOMPLEXES. Med Welt. 1964 Feb 8;17:277–282. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES